Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevention of drug-induced risks.

Deborah Szafir1, Hervé Lelouët, Jean-Louis Imbs

  • 1Laboratoire Roche, Neuilly-sur-Seine, France. deborah.szafir@roche.com

Therapie
|December 6, 2003
PubMed
Summary

Understanding drug-induced risks requires identifying their causes and ensuring quality information for prescribers and patients. Comparing drug data and implementing tailored communication plans are crucial for effective risk prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Personified prescribing. Drug compliance].

La Revue du praticien·2009
Same author

[Pharmacokinetics of cardiovascular drugs in the elderly].

Bulletin de l'Academie nationale de medecine·2007
Same author

Can colchicine potentiate the anticoagulant effect of fluindione?

European journal of clinical pharmacology·2005
Same author

[Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].

Therapie·2005
Same author

[Pharmacovigilance of hepatitis B vaccines].

Bulletin de l'Academie nationale de medecine·2004
Same author

[Diuretic therapy].

La Revue du praticien·2004

Area of Science:

  • Pharmacovigilance and drug safety
  • Risk management in medicine

Background:

  • Effective prevention of drug-induced risks is essential for patient safety.
  • Accurate identification of triggering or predisposing factors is key.
  • Quality of information impacts healthcare providers and users.

Purpose of the Study:

  • To outline a framework for understanding and preventing drug-induced risks.
  • To emphasize the importance of comprehensive data analysis and communication.

Main Methods:

  • Review of preclinical and clinical data for proprietary medicinal products.
  • Comparative analysis with drugs having similar mechanisms of action or therapeutic strategies.
  • Development of context-adapted communication plans.

Main Results:

  • Identification of risk factors relies on thorough data review and comparison.
  • Effective risk communication requires tailoring information to disease context, alternatives, and expected benefits.

Conclusions:

  • A systematic approach to data analysis and communication planning is vital for preventing drug-induced risks.
  • Informed decision-making by practitioners and users enhances medication safety.

Related Experiment Videos